Google Chrome
Safari
Firefox
Edge
Continuous Flow
Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.
Search
Article / Sep 27, 2021
How the drug services industry found itself prepared for a pandemic
C&EN, 26 September 2021
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Press Clipping / May 12, 2025
Partnership advances liver cancer treatment
Scientist Live, 12 May 2025
Press Release / May 07, 2026
Hovione and IDC Intranasal Drug Delivery Platform Available for Commercial Partnerships
Its lead single-use nasal dry powder device now available for commercial partnerships
Devices
Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
News / Sep 17, 2021
World Patient Safety Day 2021
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.